Pembrolizumab,Lenvatinib,Regorafenib,Trifluridine Tipiracil
Merck,Eisai,Bayer,Taiho pharma,Pfizer
['gi ']
yesterday's sessions are now available on demand current immuno-oncology approaches &amp; the future for new combinations in gi cancers talk by dr. morelli, md, phd #asco23 leap-017 ph 3 (-)
#brafv600e: immunereactive tme?
cell tx+io? non-liver met pts did better 
Pt Adv, NCI Rectal Anal TF
Mom
Vety Dr 
Lifelong learner
Wants to bring pt voice to research clinical trials & more!
Check out @CRCTrialsChat
1st love: Virology